Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Vaxart, Inc. (VXRT)
|
Add to portfolio |
|
|
|
| Price: |
$5.52
| | Metrics |
| OS: |
152.0
|
M
| |
|
|
| Market cap: |
$839
|
M
| |
|
|
|
Net cash:
|
$49.3
|
M
| |
$0.32
|
per share
|
|
EV:
|
$790
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($105)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Jun-30-17 | Jun-30-16 |
| Revenues | 0.1 | 0.9 | 4.0 | 9.9 | 4.2 | 5.8 | 8.9 | 9.3 |
| Revenue growth | -88.0% | -78.0% | -59.0% | 137.1% | -28.8% | | -4.3% | -62.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | -25.6 | 0.0 | 15.9 | 36.4 | 34.5 |
| Gross profit | 0.1 | 0.9 | 4.0 | 35.5 | 4.2 | -10.0 | -27.5 | -25.2 |
| Gross margin | 100.0% | 100.0% | 100.0% | 360.1% | 100.0% | -171.5% | -309.0% | -271.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 81.1 | 48.7 | 19.9 | 14.5 | 17.3 | 12.4 | 28.3 | 26.3 |
| General and administrative | 29.4 | 21.9 | 15.2 | 6.2 | 6.7 | 3.5 | 8.0 | 8.0 |
| EBITA | -109.0 | -68.0 | -29.3 | -8.6 | -17.1 | -13.3 | -27.5 | -25.2 |
| EBITA margin | -101900.0% | -7628.6% | -724.6% | -86.8% | -410.6% | -227.6% | -309.0% | -271.0% |
| Amortization of intangibles | 1.3 | 1.7 | 1.7 | 2.3 | 2.7 | 0.0 | | |
| EBIT | -110.3 | -69.7 | -31.0 | -10.9 | -19.8 | -13.3 | -27.5 | -25.2 |
| EBIT margin | -103115.0% | -7819.2% | -766.7% | -110.2% | -476.2% | -227.7% | -309.0% | -271.0% |
| Pre-tax income | -107.7 | -70.4 | -32.0 | -18.2 | -17.9 | -9.6 | -29.1 | -25.4 |
| Income taxes | 0.1 | 0.1 | 0.2 | 0.5 | 0.1 | 0.0 | 0.3 | 0.0 |
| Tax rate | | | | | | 0.0% | | 0.0% |
| Net income | -107.8 | -70.5 | -32.2 | -18.6 | -18.3 | -12.5 | -29.4 | -25.4 |
| Net margin | -100708.4% | -7900.2% | -796.3% | -189.1% | -441.1% | -213.4% | -330.3% | -273.1% |
| |
| Diluted EPS | ($0.84) | ($0.58) | ($0.36) | ($0.86) | ($2.90) | ($91.65) | ($0.76) | ($0.66) |
| Shares outstanding (diluted) | 127.7 | 121.5 | 88.3 | 21.6 | 6.3 | 0.1 | 38.6 | 38.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|